THE Health Department has released new guidelines for botulinum toxin, allowing prescribers to write two scripts for the medication on the same day where a patient requires treatment for two different conditions.
The changes become effective from 01 Mar 2017, and apply to all botulinum toxin medicines supplied under the PBS.
Patient and prescriber eligibility criteria remain unchanged - for more details see the updated FAQ document at www.pbs.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Feb 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Feb 17
